Total Debt for West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported total debt is $316.20M USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal DebtSwitch metric
Latest period
$316.20M
YoY change
+36.5%
5Y CAGR
+5.1%
Peak year (2025)
$416.70M
Latest annual
$416.70M
Total Debt history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Total Debt history table for West Pharmaceutical Services (WST) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $416.70M | +36.5% | ||
| 2024 | $305.30M | -1.2% | ||
| 2023 | $309.00M | -2.8% | ||
| 2022 | $317.90M | -2.3% | ||
| 2021 | $325.30M | -0.1% | ||
| 2020 | $325.70M | -1.1% | ||
| 2019 | $329.30M | +67.9% | ||
| 2018 | $196.10M | -0.5% | ||
| 2017 | $197.00M | -13.8% | ||
| 2016 | $228.60M | -23.3% | ||
| 2015 | $298.20M | -11.1% | ||
| 2014 | $335.50M | -10.2% | ||
| 2013 | $373.50M | -9.2% | ||
| 2012 | $411.50M | +17.8% | ||
| 2011 | $349.40M | -2.5% | ||
| 2010 | $358.40M | -5.6% | ||
| 2009 | $379.60M | -1.7% | ||
| 2008 | $386.00M | -2.3% | ||
| 2007 | $395.10M | +67.2% | ||
| 2006 | $236.30M | -15.9% | ||
| 2005 | $281.00M | +74.8% | ||
| 2004 | $160.80M | -8.1% | ||
| 2003 | $175.00M | 0.0% | ||
| 2002 | $175.00M | -9.3% | ||
| 2001 | $193.00M | -3.2% | ||
| 2000 | $199.40M | +16.5% | ||
| 1999 | $171.10M | +21.3% | ||
| 1998 | $141.10M | +58.5% | ||
| 1997 | $89.00M | -9.6% | ||
| 1996 | $98.40M | -13.9% | ||
| 1995 | $114.30M | +97.8% | ||
| 1994 | $57.80M | +78.9% | ||
| 1993 | $32.30M | -23.3% | ||
| 1992 | $42.10M | -27.9% | ||
| 1991 | $58.40M | -25.6% | ||
| 1990 | $78.50M | +35.1% | ||
| 1989 | $58.10M | +5.4% | ||
| 1988 | $55.10M | -8.9% | ||
| 1987 | $60.50M | +36.6% | ||
| 1986 | $44.30M | +45.7% | ||
| 1985 | $30.40M | — |
Total Debt values are taken from West Pharmaceutical Services's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, West Pharmaceutical Services (WST) total debt totalled $416.70M – surged 36.5% year-over-year.
Through 2020–2025 (5 years), West Pharmaceutical Services total debt delivered a +5.1% annualised rate; with the latest reading among the more recent periods of the dataset.
$416.70M stands as the all-time-high annual total debt, posted in 2025, against a low of $30.40M during 1985.
Within Healthcare, West Pharmaceutical Services (WST) ranks 9th among 8 peers we track. The peer median for total debt is $52.57B.
West Pharmaceutical Services Total Debt by Year
West Pharmaceutical Services Total Debt 2025: $416.70M
West Pharmaceutical Services total debt in 2025 was $416.70M, surged 36.5% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Total Debt 2024: $305.30M
West Pharmaceutical Services total debt in 2024 was $305.30M, edged down 1.2% below 2023.
West Pharmaceutical Services Total Debt 2023: $309.00M
West Pharmaceutical Services total debt in 2023 was $309.00M, edged down 2.8% below 2022.
West Pharmaceutical Services Total Debt 2022: $317.90M
West Pharmaceutical Services total debt in 2022 was $317.90M, edged down 2.3% below 2021.
West Pharmaceutical Services Total Debt 2021: $325.30M
West Pharmaceutical Services total debt in 2021 was $325.30M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — Total Debt
Companies in the same sector as West Pharmaceutical Services, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's total debt?
- Latest reported total debt for West Pharmaceutical Services (WST) is $316.20M (period ending March 31, 2026).
How has West Pharmaceutical Services total debt changed year-over-year?
- West Pharmaceutical Services (WST) total debt changed +36.5% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services total debt?
- West Pharmaceutical Services (WST) total debt compound annual growth rate is +5.1% over the most recent 5 years available.
When did West Pharmaceutical Services total debt hit its highest annual value?
- West Pharmaceutical Services total debt reached its highest annual value of $416.70M in 2025.
What was West Pharmaceutical Services total debt in 2024?
- West Pharmaceutical Services (WST) total debt in 2024 was $305.30M.
What was West Pharmaceutical Services total debt in 2025?
- West Pharmaceutical Services (WST) total debt in 2025 was $416.70M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.